'IV Cocktail' Ads Stir FTC To Prioritize Health Enforcement
Law360 (September 25, 2018, 9:14 PM EDT) -- The Federal Trade Commission last week required a company to stop marketing its intravenous therapy "cocktails" as a treatment for serious diseases without scientific proof, a first-of-its-kind action that signals the...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
